About Haselmeier
Haselmeier is a company based in Stuttgart (Germany) founded in 1920 was acquired by Sulzer in August 2020. The company has 49 employees as of April 07, 2024. Haselmeier offers products and services including Autoinjectors, Injection Pens, PiccoJect, D-Flex, and Re-Vario. Haselmeier operates in a competitive market with competitors including Insulet, Lyra Therapeutics, Credence MedSystems, TriSalus Life Sciences and Sixfold Bioscience, among others.
- Headquarter Stuttgart, Germany
- Employees 49 as on 07 Apr, 2024
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Haselmeier India Private Limited
- Date of Incorporation 03 Aug, 2011
- Jurisdiction Bangalore, Karnataka, India
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Haselmeier
Haselmeier offers a comprehensive portfolio of products and services, including Autoinjectors, Injection Pens, PiccoJect, D-Flex, and Re-Vario.
Devices for self-injection of fixed doses with hidden needles.
Pens for administering variable doses in disposable or reusable forms.
Compact autoinjector for single fixed doses in medical applications.
Pen for multiple fixed pre-set doses in drug delivery.
Reusable pen for variable doses in self-injection solutions.
Funding Insights of Haselmeier
Detailed funding history for Haselmeier
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investors in Haselmeier
Haselmeier has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include Sulzer.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Manufacturer of industrial flow control and applicator equipment
|
Locked | Locked | Locked |
Investor details for Haselmeier
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Haselmeier
Investment portfolio details for Haselmeier
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Haselmeier
Detailed financials for Haselmeier
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Haselmeier Comparisons
Peer comparison for Haselmeier
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Haselmeier
Haselmeier operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Insulet, Lyra Therapeutics, Credence MedSystems, TriSalus Life Sciences and Sixfold Bioscience, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Wearable insulin infusion systems are developed for diabetes patients.
|
|
| Locked | Locked | Locked |
Small molecule therapeutics for ENT diseases are developed.
|
|
| Locked | Locked | Locked |
Developer of smart devices for drug delivery
|
|
| Locked | Locked | Locked |
Developer of drug delivery devices to treat cancers
|
|
| Locked | Locked | Locked |
Oligonucleotide delivery systems are developed for targeted gene therapy.
|
|
| Locked | Locked | Locked |
Phospholipid drug conjugates for cancer treatment are developed.
|
Detailed competitors of Haselmeier
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Haselmeier
Complete news archive for Haselmeier
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Haselmeier
Haselmeier was founded in 1920.
Haselmeier is headquartered in Stuttgart, Germany. It is registered at Stuttgart, Baden-wurttemberg, Germany.
As of Apr 07, 2024, the latest employee count at Haselmeier is 49.
Annual revenue of Haselmeier is $1.28M as on Mar 31, 2023.
The company was founded in 1920 in Stuttgart, Germany, within the medical devices sector. Self-injection devices for pharmaceuticals are developed and manufactured, including pen injectors for manual, auto, reusable, disposable, hidden needle, multiple, variable dosage, and fixed dosage applications. Operations involve 200 team members across Europe, the United States, India, and China. Manufacturing facilities are located in Buchen im Odenwald, Germany; Dnesice, Czech Republic; and Bengaluru, India.
Haselmeier's top competitors include Insulet, Lyra Therapeutics and Halozyme.
Haselmeier offers Autoinjectors, Injection Pens, PiccoJect, D-Flex, and Re-Vario.
Haselmeier has 1 investor. Key investors include Sulzer.